Cargando…

Use of a GP-endorsed non-participant reminder letter to promote uptake of bowel scope screening: A randomised controlled trial in a hard-to-reach population

Previous research suggests that sending non-participants a reminder letter, 1 year after their initial invitation, can improve coverage for bowel scope screening (BSS), also known as flexible sigmoidoscopy screening. We hypothesised that adding a general practitioner's (GPs) endorsement to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaushal, Aradhna, Hirst, Yasemin, Tookey, Sara, Kerrison, Robert S., Marshall, Sarah, Prentice, Andrew, Vulkan, Daniel, Duffy, Stephen, von Wagner, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732700/
https://www.ncbi.nlm.nih.gov/pubmed/33022321
http://dx.doi.org/10.1016/j.ypmed.2020.106268
_version_ 1783622152102084608
author Kaushal, Aradhna
Hirst, Yasemin
Tookey, Sara
Kerrison, Robert S.
Marshall, Sarah
Prentice, Andrew
Vulkan, Daniel
Duffy, Stephen
von Wagner, Christian
author_facet Kaushal, Aradhna
Hirst, Yasemin
Tookey, Sara
Kerrison, Robert S.
Marshall, Sarah
Prentice, Andrew
Vulkan, Daniel
Duffy, Stephen
von Wagner, Christian
author_sort Kaushal, Aradhna
collection PubMed
description Previous research suggests that sending non-participants a reminder letter, 1 year after their initial invitation, can improve coverage for bowel scope screening (BSS), also known as flexible sigmoidoscopy screening. We hypothesised that adding a general practitioner's (GPs) endorsement to the reminder letter could improve coverage even further. We conducted a randomised controlled trial in North West London, UK. Participants were screening-eligible men and women who had not responded to their initial BSS invitation at least 12 months prior to the trial period. Eligible adults were randomised in a 1:1 ratio to receive either a GP-endorsed reminder letter, or a standard reminder letter from June to August 2019. Logistic regression models were used to test the effect of the GP endorsement on attendance at BSS, adjusting for sex, clinical commissioning group, and local area socioeconomic deprivation. In total, 1200 participants were enrolled into the study and randomised to either the control (n = 600) or the intervention (n = 600) group. Those who received the GP-endorsed reminder letter were only slightly more likely to attend BSS than those who received the standard reminder letter (4% vs. 3%); this difference was not statistically significant (Adjusted OR = 1.30; 95% CI: 0.69, 2.43). Adding a GP-endorsement to the annual reminder letter did not have an effect on attendance at BSS. One possible explanation for this is that the endorsement used was not personalised enough. Future research should examine stronger GP-endorsements or other methods to promote uptake.
format Online
Article
Text
id pubmed-7732700
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Academic Press
record_format MEDLINE/PubMed
spelling pubmed-77327002020-12-16 Use of a GP-endorsed non-participant reminder letter to promote uptake of bowel scope screening: A randomised controlled trial in a hard-to-reach population Kaushal, Aradhna Hirst, Yasemin Tookey, Sara Kerrison, Robert S. Marshall, Sarah Prentice, Andrew Vulkan, Daniel Duffy, Stephen von Wagner, Christian Prev Med Article Previous research suggests that sending non-participants a reminder letter, 1 year after their initial invitation, can improve coverage for bowel scope screening (BSS), also known as flexible sigmoidoscopy screening. We hypothesised that adding a general practitioner's (GPs) endorsement to the reminder letter could improve coverage even further. We conducted a randomised controlled trial in North West London, UK. Participants were screening-eligible men and women who had not responded to their initial BSS invitation at least 12 months prior to the trial period. Eligible adults were randomised in a 1:1 ratio to receive either a GP-endorsed reminder letter, or a standard reminder letter from June to August 2019. Logistic regression models were used to test the effect of the GP endorsement on attendance at BSS, adjusting for sex, clinical commissioning group, and local area socioeconomic deprivation. In total, 1200 participants were enrolled into the study and randomised to either the control (n = 600) or the intervention (n = 600) group. Those who received the GP-endorsed reminder letter were only slightly more likely to attend BSS than those who received the standard reminder letter (4% vs. 3%); this difference was not statistically significant (Adjusted OR = 1.30; 95% CI: 0.69, 2.43). Adding a GP-endorsement to the annual reminder letter did not have an effect on attendance at BSS. One possible explanation for this is that the endorsement used was not personalised enough. Future research should examine stronger GP-endorsements or other methods to promote uptake. Academic Press 2020-12 /pmc/articles/PMC7732700/ /pubmed/33022321 http://dx.doi.org/10.1016/j.ypmed.2020.106268 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Kaushal, Aradhna
Hirst, Yasemin
Tookey, Sara
Kerrison, Robert S.
Marshall, Sarah
Prentice, Andrew
Vulkan, Daniel
Duffy, Stephen
von Wagner, Christian
Use of a GP-endorsed non-participant reminder letter to promote uptake of bowel scope screening: A randomised controlled trial in a hard-to-reach population
title Use of a GP-endorsed non-participant reminder letter to promote uptake of bowel scope screening: A randomised controlled trial in a hard-to-reach population
title_full Use of a GP-endorsed non-participant reminder letter to promote uptake of bowel scope screening: A randomised controlled trial in a hard-to-reach population
title_fullStr Use of a GP-endorsed non-participant reminder letter to promote uptake of bowel scope screening: A randomised controlled trial in a hard-to-reach population
title_full_unstemmed Use of a GP-endorsed non-participant reminder letter to promote uptake of bowel scope screening: A randomised controlled trial in a hard-to-reach population
title_short Use of a GP-endorsed non-participant reminder letter to promote uptake of bowel scope screening: A randomised controlled trial in a hard-to-reach population
title_sort use of a gp-endorsed non-participant reminder letter to promote uptake of bowel scope screening: a randomised controlled trial in a hard-to-reach population
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732700/
https://www.ncbi.nlm.nih.gov/pubmed/33022321
http://dx.doi.org/10.1016/j.ypmed.2020.106268
work_keys_str_mv AT kaushalaradhna useofagpendorsednonparticipantreminderlettertopromoteuptakeofbowelscopescreeningarandomisedcontrolledtrialinahardtoreachpopulation
AT hirstyasemin useofagpendorsednonparticipantreminderlettertopromoteuptakeofbowelscopescreeningarandomisedcontrolledtrialinahardtoreachpopulation
AT tookeysara useofagpendorsednonparticipantreminderlettertopromoteuptakeofbowelscopescreeningarandomisedcontrolledtrialinahardtoreachpopulation
AT kerrisonroberts useofagpendorsednonparticipantreminderlettertopromoteuptakeofbowelscopescreeningarandomisedcontrolledtrialinahardtoreachpopulation
AT marshallsarah useofagpendorsednonparticipantreminderlettertopromoteuptakeofbowelscopescreeningarandomisedcontrolledtrialinahardtoreachpopulation
AT prenticeandrew useofagpendorsednonparticipantreminderlettertopromoteuptakeofbowelscopescreeningarandomisedcontrolledtrialinahardtoreachpopulation
AT vulkandaniel useofagpendorsednonparticipantreminderlettertopromoteuptakeofbowelscopescreeningarandomisedcontrolledtrialinahardtoreachpopulation
AT duffystephen useofagpendorsednonparticipantreminderlettertopromoteuptakeofbowelscopescreeningarandomisedcontrolledtrialinahardtoreachpopulation
AT vonwagnerchristian useofagpendorsednonparticipantreminderlettertopromoteuptakeofbowelscopescreeningarandomisedcontrolledtrialinahardtoreachpopulation